Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Annals of Surgical Oncology
|
July 14, 2004
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy
Steven E Finkelstein, Jorge A Carrasquillo, John M Hoffman, et al.
Future Oncology (London, England)
|
December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity
Andre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer
Neal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
American Journal of Clinical Oncology
|
July 19, 2014
Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients
Chirag Shah, Frank A Vicini, Sameer Berry, et al.
Cancer Research
|
February 3, 2016
Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
Jan T Poleszczuk, Kimberly A Luddy, Sotiris Prokopiou, et al.
Theranostics
|
May 7, 2026
Future opportunities and nuances with the use of PSMA PET in prostate cancer (MD PET 1)
Alicia K Morgans, Christopher M Pieczonka, Evan Y W Yu, et al.
Cancer Immunology, Immunotherapy : CII
|
December 2, 2006
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location
Takashi Kakinuma, Hari Nadiminti, Anke S Lonsdorf, et al.
The Journal of Experimental Medicine
|
October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10
Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 16, 2010
Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma
Steven E Finkelstein, Timothy Carey, Ingo Fricke, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Annals of Surgical Oncology
|
July 14, 2004
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy
Steven E Finkelstein, Jorge A Carrasquillo, John M Hoffman, et al.
Future Oncology (London, England)
|
December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicity
Andre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer
Neal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
American Journal of Clinical Oncology
|
July 19, 2014
Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients
Chirag Shah, Frank A Vicini, Sameer Berry, et al.
Cancer Research
|
February 3, 2016
Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
Jan T Poleszczuk, Kimberly A Luddy, Sotiris Prokopiou, et al.
Theranostics
|
May 7, 2026
Future opportunities and nuances with the use of PSMA PET in prostate cancer (MD PET 1)
Alicia K Morgans, Christopher M Pieczonka, Evan Y W Yu, et al.
Cancer Immunology, Immunotherapy : CII
|
December 2, 2006
Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location
Takashi Kakinuma, Hari Nadiminti, Anke S Lonsdorf, et al.
The Journal of Experimental Medicine
|
October 29, 2003
Immune evasion by murine melanoma mediated through CC chemokine receptor-10
Takashi Murakami, Adela R Cardones, Steven E Finkelstein, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 16, 2010
Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma
Steven E Finkelstein, Timothy Carey, Ingo Fricke, et al.
Page
of 7